Ofqual regulates qualifications, examinations and assessments in England. Its findings relate to the SQA Level 1 Health and Safety in a Construction Environment qualification delivered in England which was withdrawn by SQA in April 2019.

SQA made the Scottish Government aware of the issue through its regular governance channels when it first arose in 2019 and have regularly updated the Scottish Government on developments throughout the process.

SQA formally notified the Scottish Government of the final and published version of the Undertaking given by the SQA to Ofqual on 11 October 2024.

Tackling alcohol related harm remains a priority for Scottish Government, and we are treating our policies to reduce alcohol and drug deaths as twin public health issues in Scotland.

We are working to ensure that people who experience harms as a result of alcohol use receive the same quality of care and support as people who experience harms as a result of drug use. We work closely with Alcohol and Drugs Partnerships and regularly monitor services through the annual ADP survey. The most recent one, reflecting activity for 2023-24, was published on 12 November 2024 and notes the following on data surveillance.

Almost all ADP areas reported having specific groups or structures in place at ADP level to inform surveillance and monitoring of drug harms or deaths. All but two (93%) of ADPs reported having a drug death review group and 77% reported having a drug trend monitoring group or early warning system.

Fewer ADPs reported groups relating to alcohol, with a quarter (27%) reporting having an alcohol death review group and 30% reporting having an alcohol harms group.

A third of ADPs reported having other structures in place for informing surveillance, which included multi-agency groups working on drug death prevention and action plan groups, wider public health monitoring which included drug and alcohol harms and sudden death groups whose remits include both drug death reviews and suicides reviews. Several ADPs indicated that alcohol harm and death review groups are currently in development.

It is our expectation that future Alcohol and Drug Partnership (ADP) funding letters will ask ADPs to undertake local alcohol death review. This message will also be reinforced in our National Specification for treatment of drug and alcohol misuse in Scotland, which is currently in development and will build on the recommendations of the forthcoming UK Clinical Guidelines for Alcohol Treatment.

Across Scotland, safety cameras are deployed through the Scottish Safety Camera Programme primarily where they have the greatest potential to reduce injury collisions and where there is evidence of both collisions and speeding. This is in accordance with criteria contained in the Scottish Safety Camera Programme Handbook. This can be viewed at: https://www.transport.gov.scot/publication/scottish-safety-camera-programme-handbook/.

An annual site prioritisation process is undertaken each year to determine new safety camera sites across our road network and to maximise the casualty reduction potential of the Programme. This national exercise acts to ensure the right camera technology is in the right place at the right time. It involves a range of partners including the three regional safety camera units, all thirty-three road authorities and Police Scotland, and acts to identify potential new camera sites which meet the minimum criteria, while at the same time assessing the performance of existing enforcement strategies.

In 2019, the site at Cumbernauld Road, Riddrie was assessed to have good speed compliance and no evidence of injury collisions with speed as a causation. A decision was taken to make this site dormant through the process set out within the Handbook. This process allows for a thorough assessment of improvements in driver behaviour over a 3 year period. In 2022, a further assessment confirmed that there had been a sustained improvement in driver behaviours during the three year dormancy period and the decision was taken to remove the site from prioritised enforcement.

As part of the annual site selection process, if this location was identified again as meeting minimum site selection criteria to redeploy, this site would be considered for reinstatement.

The legal powers to mandate the reporting of pay gaps is largely reserved to the UK Parliament and is currently limited to the reporting of gender pay gaps under the Equality Act 2010 (Gender Pay Gap Information) Regulations 2017. There is no requirement for data to be disaggregated or collected to the level of parental status and Scottish Ministers have no plans to expand pay gap reporting in this way.

The Finance Secretary wrote to the Treasury on 31 October seeking urgent clarification on the increase to employer national insurance contributions.

We are clear that this change must be fully funded so that there is no impact on our frontline services. Clarity must be provided before we set our budget in just a few weeks’ time. We also need clarity on whether funding will cover the full extent of organisations delivering public services.

We will continue to work with the hospice sector to consider opportunities to deliver pay parity with Agenda for Change for independent hospices.

In law, including under the Equality Act 2010, people are either male or female.

The Scottish Government recognises that many people may identify differently. Scotland’s Census 2022 showed that almost half of people who responded to the question on trans status or history identified as non-binary. We know too that depending on the circumstances, the law on gender reassignment discrimination might protect non-binary people.

The Scottish Government is committed to advancing equality for all LGBTQI+ people, and promoting, protecting and realising the rights of every LGBTQI+ person in Scotland. This includes trans people, and non-binary people who do not identify as either male or female.

The Non-Binary Equality Action Plan 2023-28, published last November, aims to improve equality and bring about real, positive and lasting change to the lives of non-binary people.

We will soon publish our first Progress Report which will provide detail on the steps which we have made so far towards achieving the actions in the Plan.

The regulation for the licensing, safety and efficacy of medicines is currently reserved to the UK Government and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA). Ivabradine is currently licensed in the UK for the symptomatic treatment of chronic stable angina pectoris, and the treatment of chronic heart failure.

The use of ivabradine for the treatment of postural tachycardia syndrome is an off-label indication (where the product licence does not cover the indication for which the medicine is being prescribed). Clinicians can prescribe medicines off-label, in line with local Health Board protocols where they consider there would be significant clinical benefit for an individual.

Decisions on whether to prescribe a medicine are based on an individual’s needs and are a matter for the clinical judgement of the prescribing clinician in consultation with the individual (and where appropriate their parent/s or guardian/s), informed by advice and guidance about the medicine.

Within the Scottish Government, funding for Health and Care Research comes under the policy remit of the Chief Scientist Office (CSO)

Officials from CSO met with representatives from MND Scotland on 9th February 2023 to discuss the possibility of co-funding a Clinical Academic Fellowship. Funding arrangements were agreed and a joint call for applications launched on 1 August 2023

Details of the funded fellowship are available on the CSO website

CAF/24/13 - Identifying early theragnostic targets for MND

Ms Kristine Roberts - University of Aberdeen

CAF2413abstract.pdf (scot.nhs.uk)

As the Cabinet Secretary set out to Parliament, Public Health Scotland (PHS) are being commissioned to carry out a review of the evidence for the range of options that are available to the Scottish Government under devolved powers. This important step will ensure that our work is evidence based and will deliver clear public health outcomes.

The final commission will be published in due course, and will set out the timelines for that review activity. The Scottish Government will consider PHS’ findings, and consider where the evidence supports further action or consultation on alcohol marketing restrictions. Once the evidence review is concluded the Scottish Government will consider any areas where evidence supports further consultation. No decisions have been taken yet on what these areas may be.

The following members of the Cabinet have visited a college in the last year:

• John Swinney MSP, First Minister
• Kate Forbes MSP, Deputy First Minister and Cabinet Secretary for Economy and Gaelic
• Shona Robison MSP, Cabinet Secretary for Finance and Local Government
• Neil Gray MSP, Cabinet Secretary for Health and Social Care
• Jenny Gilruth MSP, Cabinet Secretary for Education and Skills
• Gillian Martin MSP, Acting Cabinet Secretary for Net Zero and Energy
• Fiona Hyslop MSP, Cabinet Secretary for Transport
• Mairi Gougeon MSP, Cabinet Secretary for Rural Affairs, Land Reform and Islands
• Angela Constance MSP, Cabinet Secretary for Justice and Home Affairs